The varicella-zoster virus (VZV) genome contains 70 reading frames (ORF), 5 of which encode the glycoproteins gpl, gpII, gpIII, gprV, and gpV. ORF 67 and 68 lie adjacent to each other in the unique short region of the VZV genome and code for gpIV and gpl, respectively. These two genes, which are contained within the HindIII C fragment of the VZV genome, were subcloned in the correct orientation downstream from the promoter regions of the eukaryotic expression vectors pCMV5 and pBJ. After transfection, 5 to 20% of the Cos cells bound antibody specific for the given glycoprotein. In this study, it was shown that only the cells transfected with the gpI construct bound to the Fc fragment of human immunoglobulin G. Neither the transfected gpIV gene product nor the vector only bound to the Fc fragment. Thus, VZV gpI is confirmed to be the VZV-encoded Fc-binding glycoprotein. Like the wild-type form of gpI expressed in VZV-infected cells, gpl precipitated from transfected cells contained both N-linked and 0-linked glycans and was heavily sialated. In addition, the transfected gpl gene product was phosphorylated both in cell culture and in protein kinase assays by mammalian casein kinases I and II. Extensive computer-assisted analyses of the VZV gpl sequence, as well as those of alphaherpesviral homolog glycoproteins, disclosed properties similar to those of other cell surface receptors; these included (i) exocytoplasmic regions rich in cysteine residues, (ii) membrane-proximal regions with potential 0-linked glycosylation sites, and (iii) cytoplasmic domains with consensus phosphorylation sites.
Varicella-zoster virus (VZV) is one of the human herpesviruses. It is the etiologic agent of chicken pox in children and herpes zoster in adults. VZV is the first herpesvirus to have been attenuated in cell culture for the purpose of human immunization. Based on genomic organization and biologic behavior, this herpesvirus is further classified along with herpes simplex virus (HSV) types 1 and 2 as an alphaherpesvirus (32) . The genomes of the Alphaherpesvirinae are composed of two covalently linked segments, the unique long (UL) and the unique short (Us). The organization and the structure of the HSV and VZV genomes are quite similar, with some notable exceptions, e.g., the VZV genome is smaller than that of HSV, 125 kbp verses 160 kbp, and codes for fewer proteins. In regard to the number of glycoproteins, VZV specifies only five glycoproteins, while HSV codes for a greater number. At least four of the HSV glycoproteins are located in the Us region of the genome: gG, gD, gI, and gE; in contrast, only two glycoproteins are encoded within the Us genome of VZV. These two glycoproteins, gpIV and gpI, are the homologs of HSV gI and gE, respectively.
Although it is now known that each of the five glycoproteins encoded in the VZV genome has an HSV homolog (8) , only the VZV gB homolog called gpII approaches 50% identity ( Table 1) . The other four glycoproteins share considerably less sequence identity with their HSV homologs (Table 1) . Thus, it is unclear whether a functional relationship exists between homologous glycoproteins of these viruses (8, 15) . HSV-1 and HSV-2 and, more recently, VZV have been shown to induce receptors for the Fc portion of immunoglobulin G (IgG) on the surface of the infected cell (6, 7, 20, 24, 26, 29, 41) . In the HSV system, the Us * Corresponding author.
glycoprotein gE mediates the Fc-binding activity and a gE-gI complex is thought to result in an Fc receptor (FcR) of higher affinity (2, 10, 18, 21, 22) . In VZV, however, the Fc-binding activity has not yet been ascribed to a given viral glycoprotein. To address this issue, we transfected the VZV homologs of HSV gE and gI into mammalian cells and examined their products for FcR activity. This study identifies a functional relationship between the VZV Us glycoproteins and their HSV counterparts and also further outlines cell surface receptor properties shared by the VZV gpl-gpIV complex and their alphaherpesviral homologs, including pseudorabies virus (PRV) (3) .
MATERIALS AND METHODS
Cell culture. Simian cell lines derived from kidney fibroblasts, Cos-1 and Cos-7, were maintained in tissue culture in Dulbecco minimal essential medium high glucose, supplemented with 10% Nu-serum (Collaborative Research Inc., Bedford, Mass.), 2 mM L-glutamine, 100 U of penicillin per ml, 100 pLg of streptomycin per ml, 1% nonessential amino acids (GIBCO, Grand Island, N.Y.), and 1 mM Na pyruvate (Sigma). The murine L-cell fibroblast cell line DAP.3 was maintained in Eagle minimal essential medium supplemented with 10% fetal calf serum (Irvine Scientific, Irvine, Calif.), L-glutamine, penicillin, and streptomycin.
Antisera and MAb. Murine monoclonal antibodies (MAb) 3B3 and 6B5 specific for the VZV glycoproteins gpI and gpIV, respectively, have been described in detail elsewhere (15, 28) . Procedures for purification and biotinylation of MAb have also been published previously (24) .
Description of eukaryotic expression vectors. The HindlIl library of the VZV genome was prepared and cloned into pBR322 by Ecker and Hyman (11) . VZV genes 67 and 68 which code for glycoproteins gpIV and gpl, respectively, are gpI  gE  632  27  47   gpII   gB  913  49  67  gpIII   gH  683  26  48   gpIV   gI  358  24  43  gpV  gC  559  24  42 a Data were generated by using the GCG BestFit program (9, 35) . Sequences for VZV glycoproteins gpl, gpII, gpIII, and gpIV are from SwissProt AC: P09259, P09257, P09260, and P09258, respectively. Sequences for HSV glycoproteins gE, gB, gH, gI, and gC are from SwissProt AC: P04488, P10211, P06477, P06487, and P10228, respectively. Sequence for VZV gpV is from GenBank AC: X04370 (residues 21113 to 19434). ' Length refers to the number of amino acids over which the homology spans. located in the HindIII C fragment (8) . Gene 68 was first excised from the HindIII-C-pBR322 construct and ligated into the Riboprobe Gemini pGEM-blue vector (Promega, Madison, Wis.) and then shuttled into the plasmid pCMV5 (1), which was supplied by Mark Stinski (University of Iowa). The pGEM-ORF 68 construct was linearized at the Sacl site of the plasmid which is located downstream from the insert. This enzyme produced a 3' overhang which was removed by digestion with mung bean nuclease to create a blunt end. The HindlIl site of pGEM-blue located 5' to the insert was then cleaved. The HindIII-SacI fragment containing open reading frame (ORF) 68 was isolated on an agarose gel and purified with Geneclean (Bio 101, La Jolla, Calif.). This fragment was ligated in the correct orientation into pCMV5 which had been cut with HindIII (5') and SmaI (blunt, 3'). Positive clones containing ORF 68 were verified by minipreps and restriction enzyme digestion with BclI, which cuts once within the insert but does not cut pCMV5. A schematic representation of cloning strategy is depicted in Fig. 1 .
Gene 67 was likewise excised from the HindIII C fragment of pBR322 by digestion with AccI. The did not contain the selection agent. After 48 h, culture medium was replaced with medium containing 1 mg of Geneticin (G418 sulfate) (GIBCO) per ml for 2 to 3 days, at which time the concentration of G418 was reduced to 250 ,ug/ml. About 2.5 weeks posttransfection, cells were analyzed for surface expression of gpl by flow cytometry.
Immunofluorescence and flow cytometry. Transfected Cos cells were centrifuged onto microscope slides in a Cytospin centrifuge (Shandon Inc., Pittsburg, Pa.) for 10 min with slow acceleration at 1,000 rpm. The cytoslides were then dried, fixed in acetone for 10 min, and analyzed by immunofluorescence, as previously reported (24) . Methods for flow cytometric analysis of VZV-infected cells also have been reported by this laboratory (24) . For the FcR binding assay, 0.5 x 106 transfected cells were incubated with human IgG Fc fragment (Calbiochem, La Jolla, Calif.) in phosphate-buffered saline containing 0.1% NaN3 for 30 min; this was followed by a 30-min incubation with F(ab')2 fluorescein isothiocyanate-conjugated goat anti-human Ig (Tago). Cells were analyzed by fluorescence microscopy.
In vitro phosphorylation and isotopic labeling. In vitro phosphorylation of VZV glycoproteins with purified preparations of mammalian casein kinase I and casein kinase II have been described in detail previously (17, 38) . The kinases were provided by Jolinda Traugh (University of California Riverside). For isotopic labeling, Cos-1 cells were transfected by electroporation and plated in a 75-cm2 tissue culture flask. At 24 h posttransfection, culture medium was replaced with medium containing 2.5 mCi of 32p; (Amer- sham). After 48 h of incubation in the presence of isotope, cell lysates were suspended in 1.8 ml of radioimmunoprecipitation assay (RIPA) buffer and immunoprecipitated by published methods (16, 27) . For methionine labeling, culture medium was replaced with methionine-deficient minimal essential medium (Sigma) supplemented with L-[35SJmethio-nine (Amersham, Arlington Heights, Ill.) 1 day posttransfection. After an additional 2 days of incubation, the monolayers were harvested, and solubilized infected cell antigen was prepared (27, 28) . For glycosylation analyses, the glycoproteins were treated with neuraminidase, O-glycanase, and N-glycanase, according to established procedures (15, 28) (Genzyme, Cambridge, Mass.).
RESULTS
Expression of gpI and gpIV in transfected cells. The pCMV5-gpI construct and the pCMV5 vector were transfected into Cos cells by electroporation or by the DEAEdextran method as detailed in Materials and Methods. After fixation and immunofluorescence staining with the MAb 3B3, gpl antigen was easily detected throughout the cytoplasm of Cos-1 cells transfected with pCMV5-gpl (Fig. 3A) . This preponderant viral glycoprotein is present throughout the cytoplasm of VZV-infected cells (28) . To verify that gpI was being transported to the outer membrane of the transfectants, unfixed cells were similarly analyzed. Figure 3B shows that pCMV5-gpl-transfected cells exhibited bright membrane fluorescence after staining with MAb 3B3; however, no fluorescence was observed after staining with a control MAb, 251D9, directed against a nonstructural VZV protein (data not shown). Generally, the shutter interval for photographing the positive cells was 12 to 20 s. The percentage of cells displaying positive membrane staining ranged from 5 to 20% in a series of 10 experiments. When control cells transfected with pCMV5 were photographed for a similar interval, no image was detectable in the photograph (Fig. 3D) . If the camera was placed on automatic exposure, dull orange cells without specific staining were visible on film after 120 s (+30 s).
Subsequently, we attempted to establish stable cell lines expressing gpI. The pCMV-gpI construct was cotransfected along with the vector pCB6, which contains the neomycin resistance gene, into the murine L-cell line DAP.3, by the Ca2+ phosphate coprecipitation method. After transfection, cells were propagated for 2.5 weeks in the presence of G418, a neomycin analog. The positively selected cells were then analyzed for the surface expression of VZV gpI, but four rounds of this procedure failed to yield cell lines which stably expressed gpl (data not shown). The failure of gpl to be synthesized in the stable cell lines may indicate that this gene is toxic to mammalian cells. This phenomenon has been reported for other herpesviral glycoproteins (13, 38) .
The surface expression of gpIV was also assessed by indirect immunofluorescence. This glycoprotein gpIV was easily visualized in the pBJ-gpIV transfected cells, as detected with the MAb 6B5 (Fig. 3C ). Similar to transfected gpl cultures, the staining pattern observed in the unfixed cells represented that of a membrane glycoprotein. Cells transfected with pBJ alone were not similarly stained by the anti-gpIV MAb nor were pBJ-gpIV transfectants recognized by an irrelevant VZV MAb (data not shown, but similar to Fig. 3D ). Under these transfection conditions, with the (Fig. 4) . Because the transfected gpl gene product was about the same size as the gpI precipitated from VZVinfected cells, it appeared that the glycosylation and processing events of the transfected gpl were similar to those of the wild-type glycoprotein. In support of this observation, we examined the susceptibility of gpl from transfected cultures to cleavage with neuraminidase and O-glycanase (Fig. 4) . In each instance, a decrease in Mr indicated that the gpI product synthesized under transfection conditions contained both 0-linked and sialic acid residues, similar to the mature wild-type product (Fig. 4) . These analyses with O-glycanase confirmed our earlier observation that the forms of gpl synthesized in the presence of tunicamycin must contain 0-linked glycans (28) . Studies of N-linked glycosylation of the transfected gpl product are described in the penultimate section of the Results.
Characterization of gpIV from transfected cells. As shown in Fig. 3C (Fig.  5) . In contrast to MAb 3B3, which recognizes a very stable epitope on all forms of gpl (27, 28) Fc fragment when present at the two higher concentrations (Fig. 6A) ; however, no binding was observed in cells transfected with the pCMV5 vector alone (data not shown, but similar to Fig. 3D ). Within each of four transfection experiments, we consistently observed that approximately the same percentage of cells which stained positively with the MAb 3B3 also bound to the Fc fragment of human IgG. Furthermore, staining with the Fc fragment (Fig. 6A) displayed an immunofluorescence pattern typical of a membrane glycoprotein, as shown earlier in Fig. 3B .
The pCMV-gpI-transfected cells were also tested for the ability to bind to purified preparations of human IgM and IgA myeloma proteins. As with IgG, the final concentrations of IgM and IgA were 0.1, 0.5, and 1.0 mg/ml. Neither of these two isotypes bound to the transfected cells (data not shown). Thus, the specificity of the VZV FcR is confined to the IgG isotype. When cells transfected with pBJ-gpIV were tested for the ability to bind human IgG Fc fragment, no binding was observed (Fig. 6B) ; likewise, cells transfected with pBJ vector alone did not bind Fc fragment (data not shown, but similar to Fig. 6B ). Taken together, these data indicated that the VZV glycoprotein gpl, like its HSV homolog gE, contained the virally encoded Fc-binding activity. VZV gpIV by itself did not bind IgG Fc fragment. This latter finding is consistent with reports that HSV gI alone does not act as an FcR.
Phosphorylation of transfected viral products. Previously, gpl precipitated from infected cells has been shown to be modified by mammalian phosphotransferases (27) . The ability of the transfected gpl product to be similarly modified in a system free of other viral constituents was investigated.
One day after transfection, Cos-7 cells were labeled with 32pi and cultured for an additional 2 days. Figure 7A shows that a phosphorylated form of gpl was precipitated from the pCMV5-gpI transfectants, but no phosphoprotein corresponding to VZV gpI was observed in the Cos cells transfected with the vector only. Examination of the amino acid sequence of gpl reveals that the viral glycoprotein contains putative phosphorylation sites for both casein kinase I and casein kinase II in its cytoplasmic tail (15, 17) . When the transfected gpl gene product was similarly analyzed, it was also found to be modified by the same two kinases in vitro (Fig. 7A) . As a control experiment, gpl precipitated from VZV-infected cells was phosphorylated in a protein kinase assay with casein kinase II and included in lane 7. Because 32P-labeled glycoproteins are easily detectable on radiographic film, we investigated whether the radiolabeled proteins shown in Fig. 7A could be used as substrates in further oligosaccharide studies. To establish that the transfected gene product retained its N-linked glycans, we did analyses with N-glycanase on the phosphorylated molecule isolated from infected and transfected cell cultures. As shown in Fig.  7B , both gpl products were equally sensitive to digestion with this endoglycosidase, which cleaves high-mannose and complex-type oligosaccharide moieties. The electrophoretic pattern in Fig. 7B the regions of HSV gE amino acids 211 to 381, VZV gpI amino acids 328 to 500, and PRV gI amino acids 213-376. Six of the 10 extracellular cysteine residues of VZV gpI are located in the region between residues 328 and 500. The Petrovskis analysis revealed that these six cysteine residues were conserved across the three viruses.
In Table 2 , we show the results of further examination of the sequences of these three viral glycoprotein homologs, in particular, the regions downstream from those analyzed by Petrovskis et al. (31) . VZV gpI shares an overall amino acid sequence identity of 27% with HSV gE and 30% with PRV gI. In the downstream regions, the amino acid sequence identity was only mildly reduced to 24% for HSV gE and to ,0. a 27% for PRV gI. Similar motifs among the three viral glycoproteins are detailed in Fig. 8 . For example, a serinethreonine-proline-rich region 5' proximal to the transmembrane domain of a receptor is indicative of potential 0-linked glycosylation sites (34) . Examination of similar regions in the three alphaherpesviruses yielded values of 43% serinesthreonines-prolines in VZV gI, 32% in HSV gE, and 50% in PRV gI. Another shared motif relates to phosphorylation.
VZV gpI is known to contain consensus sequences for mammalian protein kinases near its carboxy terminus (15, 17) ; likewise, the cytoplasmic region of HSV gE had nearly identical sites for phosphorylation by both enzymes. Although not as apparent, a consensus sequence was also (6, 7, 26) . In earlier investigations of the VZV FcR, conditions which were favorable for detection of FcR activity in HSV-infected cells failed to uncover FcR activity in VZV-infected cells (12, 14, 19) . This discrepancy is most likely due to the lower affinity of the VZV receptor for Ig. The differences in the properties of the VZV and HSV receptors may be reflective of the fact that the two viral glycoproteins share only 27% amino acid sequence identity ( (32) .
